Systematic literature review on sterile injectable dates of use, stability and implications for use
DOI:
https://doi.org/10.70347/svsthya.v2i1.66Keywords:
Drug Stability, patient safety, sterile injectable, dates of use, quality control, drug storageAbstract
Beyond-use date (BUD) is crucial for the stability of injectable preparations. However, there is a knowledge gap and a lack of information regarding BUD determination in injection preparations. Therefore, a systematic review is needed to address the BUD of injection preparations. This study aimed to provide comprehensive insights into the stability, BUD data, and associated implications for injectable preparations through a systematic literature review approach. This study employed a systematic literature review guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). The inclusion criteria were research articles from national and international journals discussing the BUD of sterile injection preparations published in the last 10 years. Fourteen of the 19 articles related to BUD were selected for analysis. The analysis revealed that the stability of the 19 sterile injection preparations was significantly influenced by the characteristics of the preparation, storage conditions, and type of drug. These factors substantially affect the effectiveness and safety of drugs. Intravenous sterile injections involve several critical steps to ensure the safety and efficacy of the medications used. Adhering to BUD guidelines for intravenous injections is crucial for maintaining drug quality, which can help prevent infections or adverse reactions in patients. The stability of sterile injection preparations, which is influenced by various factors, has direct implications for BUD determination. This review highlights the importance of considering these factors when determining BUD to ensure patient safety.
Downloads
References
WHO. Patient Safety 2023. https://www.who.int/news-room/fact-sheets/detail/patient-safety. Accessed October 20, 2024
Panagioti M, Khan K, Keers RN, Abuzour A, Phipps D, Kontopantelis E, et al. Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis. BMJ 2019:l4185. https://doi.org/10.1136/bmj.l4185.
Hodkinson A, Tyler N, Ashcroft DM, Keers RN, Khan K, Phipps D, et al. Preventable medication harm across health care settings: a systematic review and meta-analysis. BMC Med 2020;18:313. https://doi.org/10.1186/s12916-020-01774-9.
EMA. Good practice guide on risk minimisation and prevention of medication errors. EMA/606103/2014 pharmacovigilance risk assessment committee (PRAC) 2015;44:1–36.
Flynn EA, Pearson RE, Barker KN. Observational study of accuracy in compounding i.v. admixtures at five hospitals. Am J Health-Syst Pharm 1997;54:904–12. https://doi.org/10.1093/ajhp/54.8.904.
Fahimi F, Ariapanah P, Faizi M, Shafaghi B, Namdar R, Ardakani MT. Errors in preparation and administration of intravenous medications in the intensive care unit of a teaching hospital: An observational study. Aust Crit Care 2008;21:110–6. https://doi.org/10.1016/j.aucc.2007.10.004.
Kementrian Kesehatan Republik Indonesia. Farmakope Indonesia Edisi VI 2020. https://farmalkes.kemkes.go.id/2020/11/farmakope-indonesia-edisi-vi/
Gray A. Injectable Drug Guide. 1st ed. London: Royal Pharmaceutical Society; 2012. http://repo.upertis.ac.id/1903/1/Injectable%20%20Drug%20Guide.pdf. Accessed October 20, 2024
United States Pharmacopeial (USP). Pharmaceutical compounding-sterile preparations 2019. https://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/revisions/gc-797-postponement-rb-notice-20191122.pdf. Accessed October 20, 2024
Herawati F. Beyond Use Date (BUD). Buletin Rasional 2016;10:16–24. https://www.researchgate.net/profile/Fauna-Herawati/publication/311669171_Beyond_Use_Date/links/5853656e08ae0c0f32227bac/Beyond-Use-Date.pdf. Accessed October 20, 2024
Adnyana IMDM. Meta Analisis. In: Akbar H, editor. Biostatistika Epidemiologi. 1st ed., Bandung: CV. Media Sains Indonesia; 2023, p. 185–205.
Perks W, Iazzetta J, Chan PC, Brouzas A, Law S, Walker SE. Extended stability of sodium phosphate solutions in polyvinyl chloride bags. Can J Hosp Pharm 2017;70:1622. https://doi.org/10.4212/cjhp.v70i1.1622.
Rush SD, Kim SE, Hughes SE, Gilbert JM, Ciancaglini PP, Zhao F. Stability of glutamate-aspartate cardioplegia additive solution in polyolefin IV Bags. Hosp Pharm 2015;50:522–5. https://doi.org/10.1310/hpj5006-522.
Hutchinson HM, Sayre BE, Prettyman T, King E. Evaluating sterility of single dose vials on an automated compounding device. Hosp Pharm 2017;52:286–93. https://doi.org/10.1310/hpj5204-286.
Hopkins JN, Waldman M, Sahai R, Battle J. Evaluating drug stability and sterility in single-dose vials when accessed with a closed system transfer device. SAGE Open Med 2024;12:20503121241230450. https://doi.org/10.1177/20503121241230449.
Walker SE, Law S, Perks W, Iazzetta J. Stability of Ertapenem 100 mg/mL in Manufacturer’s glass vials or syringes at 4°C and 23°C. Can J Hosp Pharm 2015;68:1437. https://doi.org/10.4212/cjhp.v68i2.1437.
Porlier A, Gagnon P-Y, Chénard V, Veillette M, Bertrand N, Duchaine C, et al. Stability of opened durvalumab (IMFINZI) vials. the beginning of the end of costly product wastage? J Pharm Sci 2023;112:2412–8. https://doi.org/10.1016/j.xphs.2023.06.014.
Moya-Gil A, Martínez-Gómez MA, Porta-Oltra B, Merino-Sanjuán M, Climente-Martí M. Physico-chemical stability of admixtures of vinflunine used in clinical practice. J Pharm Sci 2021;110:2687–93. https://doi.org/10.1016/j.xphs.2021.02.021.
Shi S, Hashemi V, Wang S-C, Yang J, Yang M (Mei), Semple A, et al. Overcoming Challenges With Intravenous administration of an investigational protein therapeutic. J Pharm Sci 2017;106:3465–73. https://doi.org/10.1016/j.xphs.2017.07.018.
Fleming K, Donnelly RF. Physical compatibility and chemical stability of injectable and oral ranitidine solutions. Hosp Pharm 2019;54:32–6. https://doi.org/10.1177/0018578718763085.
Buga I, Uzoma JI, Reindel K, Rashid K, Diep T, McCartan P, et al. Physical and Chemical Stability of dexamethasone sodium phosphate in intravenous admixtures used to prevent chemotherapy-induced nausea and vomiting. Hosp Pharm 2021;56:215–20. https://doi.org/10.1177/0018578719888912.
Garcia J, Garg A, Song Y, Fotios A, Andersen C, Garg S. Compatibility of intravenous ibuprofen with lipids and parenteral nutrition, for use as a continuous infusion. PLoS One 2018;13:e0190577. https://doi.org/10.1371/journal.pone.0190577.
Pereira LM, Matte GS, Lutz P, Arnold A, Patterson A. Production standard and stability of compounded del nido cardioplegia solution. Hosp Pharm 2017;52:766–73. https://doi.org/10.1177/0018578717738510.
Friciu M, Marcelin RB, Bédard P, Forest J-M, Leclair G. Stability of compounded digoxin solution 0.05 mg/mL for injection. Hosp Pharm 2022;57:294–9. https://doi.org/10.1177/00185787211029545.
Luu Y, Thigpen J, Brown SD. Stability of sildenafil in combination with heparin and dopamine. Am J Health-Syst Pharm 2017;74:e64–71. https://doi.org/10.2146/ajhp150853.
Sagitha IGE, Suharjono S, Yulistiani Y, Isnaeni I. Uji stabilitas sediaan ampisilin sulbaktam setelah rekonstitusi [eng: Stability test of ampicillin sulbactam preparation after reconstitution]. Pharma Xplore: Jurnal Sains dan Ilmu Farmasi 2023;8:77–90. https://doi.org/10.36805/jpx.v8i1.4333.
NAPRA. Model Standards for Pharmacy Compounding of Non-sterile Preparations. Ottawa: 2022. https://www.napra.ca/publication/model-standards-for-pharmacy-compounding-of-non-sterile-preparations/
Engel J, Lazar N. Guidelines for the establishment of appropriate beyond use dating of sterile compounded admixtures. Hosp Pharm 2016;51:654–703. https://doi.org/10.1310/hpj5108-654.
Institute for Safe Medication Practices. ISMP Guidelines for Safe Preparation of Compounded Sterile Preparations. Instituté for Safe Medication Practices 2016:22.
Rich DS, Fricker MP, Cohen MR, Levine SR. Guidelines for the safe preparation of sterile compounds: results of the ISMP Sterile preparation compounding safety summit of october 2011. Hosp Pharm 2013;48:282–301. https://doi.org/10.1310/hpj4804-282.
United States Pharmacopeial (USP). BUD Reference for the 2021 Proposed Revisions to <795>. The United States Pharmacopeial Convention Inc 2021:1–3.
Al-Fadel N, Mahmoud MA, Dabliz R, Tabbara O, Aljadhey H. Implementation of safety standards of compounded sterile preparations in hospital pharmacies: a multinational cross-sectional study. Eur J Hosp Pharm 2016;23:339–42. https://doi.org/10.1136/ejhpharm-2015-000872.
ASHP. ASHP guidelines on compounding sterile preparations. Am J Health-Syst Pharm 2014;71:145–66. https://doi.org/10.2146/sp140001.

Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 I Gst A A Gangga Samala Dewi, Lucienne Agatha Larasati Nugraha Putri, Lydia Devy Silalahi, I Gusti Ayu Widha Paramistya Dewi, Meivanti Diva Hapsari, Julio Angga Purnama Dewa, Kadek Ayu Mas Sarayawati, I Wayan Sindhu Wahyu Prasetya, Ni Pande Kadek Sinta Dewi, Ni Putu Rika Noviyanti, Putri Ayu Puspita Sari , Ni Kadek Ida Rajeswari, Ni Luh Komang Wahyuni, Dewi Wulandari, Ni Kadek Warditiani (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This license enables reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.